Literature DB >> 18381564

Identification of regions required for apical membrane localization of human multidrug resistance protein 2.

Paul E Bandler1, Christopher J Westlake, Caroline E Grant, Susan P C Cole, Roger G Deeley.   

Abstract

Multidrug resistance proteins MRP1 and MRP2 transport a wide range of endo- and xenobiotics. However, with the exception of certain parts of the brain, MRP1 traffics to basolateral membranes of polarized cells, whereas MRP2 is apical in location and thus it is particularly important for systemic elimination of such compounds. Different regions of MRP1 and MRP2 seem to target them to their respective membrane locations. In addition to two "core" membrane spanning domains (MSDs) characteristic of ATP-binding cassette transporters, MRP1 and MRP2 have a third NH2-terminal MSD (MSD0), which is not required for basolateral targeting of MRP1, or for transport of at least some substrates. Here, we demonstrate that all elements necessary for apical targeting of MRP2 reside in MSD0 and the adjacent cytoplasmic loop (CL) 3. Furthermore, we show that this region of MRP2 can target the core of MRP1 to an exclusively apical location. Within MRP2 CL3, we identified a lysine-rich element that is essential for apical targeting. When introduced into MRP1, this element alone is sufficient to result in partial apical localization. However, exclusive targeting to the apical membrane seems to require the integrity of the entire region encompassing MSD0 and CL3 of MRP2. Because CL3 of MRP1 is critical for binding, transport, or both of several compounds, we also examined the function of hybrids containing all, or portions of MRP2 MSD0 and CL3. Our results indicate that CL3 is important for interaction with both the glutathione and glucuronide conjugates tested, but that different regions may be involved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381564     DOI: 10.1124/mol.108.045674

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  21 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

2.  In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants.

Authors:  Xia Wen; Melanie S Joy; Lauren M Aleksunes
Journal:  Pharm Res       Date:  2017-04-12       Impact factor: 4.200

Review 3.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Conformational stabilization of the membrane embedded targeting domain of the lysosomal peptide transporter TAPL for solution NMR.

Authors:  Franz Tumulka; Christian Roos; Frank Löhr; Christoph Bock; Frank Bernhard; Volker Dötsch; Rupert Abele
Journal:  J Biomol NMR       Date:  2013-09-07       Impact factor: 2.835

5.  Molecular and structural characteristics of multidrug resistance-associated protein 7 in Chinese liver fluke Clonorchis sinensis.

Authors:  Fuhong Dai; Won Gi Yoo; Ji-Yun Lee; Yanyan Lu; Jhang Ho Pak; Woon-Mok Sohn; Sung-Jong Hong
Journal:  Parasitol Res       Date:  2017-01-05       Impact factor: 2.289

6.  Identification of a human ABCC10 orthologue in Catharanthus roseus reveals a U12-type intron determinant for the N-terminal domain feature.

Authors:  Taissir El-Guizani; Clotilde Guibert; Saida Triki; Benoit St-Pierre; Eric Ducos
Journal:  J Genet       Date:  2014-04       Impact factor: 1.166

Review 7.  Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases.

Authors:  Zhe-Sheng Chen; Amit K Tiwari
Journal:  FEBS J       Date:  2011-08-01       Impact factor: 5.542

Review 8.  Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Brain Res       Date:  2015-03-18       Impact factor: 3.252

Review 9.  ABC transporters in Saccharomyces cerevisiae and their interactors: new technology advances the biology of the ABCC (MRP) subfamily.

Authors:  Christian M Paumi; Matthew Chuk; Jamie Snider; Igor Stagljar; Susan Michaelis
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

Review 10.  Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities.

Authors:  Macus Tien Kuo
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.